← Evidence map

ReviewDrugs2019

Risankizumab: First Global Approval.

Kate McKeage et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31098898